February 20, 2020
Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.
June 18, 2020
The BioTech Pharma Summit: CDX, Biomarkers & Biobanking will insight into how the biobanking industry at the forefront at driving precision medicine and the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas
The 4th Annual Biosimilars Summit 2020 is the leading event to continually stay on the pulse of the biosimilars’ ever-changing market and convenes key stakeholders including biosimilar and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biosimilar product success